Shares in Genedrive jumped 14.4% to 41.5p on Wednesday.
The group’s shares surged after it was approved to sell products in the UK.
- Advertisement -
CEO David Budd said: “The next milestone is approval by the Department of Health and Social Care. However, no assured timeline is provided on how long the review under CTDA regulations will take, given a current backlog in their reviews.”
“We have confidence in our data and the application is another positive step that allows us now to progress UK focused commercial discussions.”
The tests can show a positive results within seven minutes, whilst a negative result can take up to 17 minutes. They have 98% sensitivity.